Nombre del producto |
Espiramicina, hexanodioato (1:1) (sal) |
Sinónimos |
Adipato de espiramicina; Ácido hexanodioico, compuesto por espiramicina (1:1); Mamivert; RP 5337; Espiramicina, hexanodioato (sal); Suanovil; ácido hexanodioico - [(4R,) 5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihidroxi-4,6-dimetiltetrahidro-2H-pirano-2-il]oxi}-4-(dimetilamino)-3-hidroxi-6-metiltetrahidro-2H-pirano-2-il]oxi}-10-{[(5S,6R)-5-(dimetilamino)-6-metiltetrahidro-2H-pirano-2-il]oxi}-4-hidroxi-5-metoxi-9,16-dimetil-2-oxooxaciclohexadeca-11,13-dien-7-il]acetaldehído (1:1) (nombre no preferido); HEXANODIOATO DE ESPIRAMICINA |
Nombre en inglés |
Spiramycin, hexanedioate (1:1) (salt);Spiramycin adipate; Hexanedioic acid, compd. with spiramycin (1:1); Mamivert; RP 5337; Spiramycin, hexanedioate (salt); Suanovil; hexanedioic acid - [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde (1:1) (non-preferred name); SPIRAMYCIN HEXANEDIOATE |
Fórmula molecular |
C49H84N2O18 |
Peso Molecular |
989.1939 |
InChI |
InChI=1/C43H74N2O14.C6H10O4/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34;7-5(8)3-1-2-4-6(9)10/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3;1-4H2,(H,7,8)(H,9,10)/b13-12+,16-14+;/t24-,25-,26-,27-,28+,29+,30+,31-,32+,34?,35+,36-,37-,38-,39+,40+,41+,42+,43-;/m1./s1 |
Número de registro CAS |
68880-55-7 |
EINECS |
272-570-0 |
Estructura Molecular |
|
Punto de ebullición |
913.7°C at 760 mmHg |
Punto de inflamación |
506.4°C |
Presión de vapor |
0mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|